tiprankstipranks
Trending News
More News >
OrganoClick AB (SE:ORGC)
:ORGC

OrganoClick AB (ORGC) Price & Analysis

Compare
0 Followers

ORGC Stock Chart & Stats

kr1.78
kr0.00(0.00%)
At close: 4:00 PM EST
kr1.78
kr0.00(0.00%)

Bulls Say, Bears Say

Bulls Say
Sustainable Bio-based Technology PlatformOrganoClick’s core bio-based chemistry platform targets material modification and surface treatment across wood and textile applications. That platform-level IP and product focus create structural differentiation in sustainability-oriented markets and support cross-industry application and collaboration potential over time.
Diversified B2B And B2C Revenue ChannelsThe company sells both industrial bio-based formulations to manufacturers and branded consumer products via retail/e-commerce. This dual-channel model provides durable revenue diversification, multiple commercialization routes, and optional licensing/collaboration pathways that can sustain growth as one channel faces cyclicality.
Historical Gross Margin ImprovementReported improvement in gross margin versus 2022 indicates periods of better cost structures or pricing power. Sustained higher gross margins are the main structural lever to convert revenues into lasting operating profits once volume and fixed-cost absorption stabilize.
Bears Say
Persistent And Worsening LossesThe company has been loss-making across reported years with a steep deterioration to ~-34% net margin in 2025 and widening operating losses. Persistent negative profitability erodes retained capital, forces external funding needs, and makes long-term viability dependent on material margin recovery.
Negative Operating And Free Cash FlowOperating cash flow moved negative in 2025 and free cash flow has been negative throughout the reported periods, indicating ongoing cash burn. Weak cash generation limits the company’s ability to self-fund growth, increases reliance on financing, and constrains resilience to shocks.
Sharp Rise In Leverage And Weakened Equity BaseLeverage increased markedly to ~6.4x debt-to-equity as equity shrank and debt rose, while ROE is deeply negative (~-240%). High leverage amid losses amplifies solvency risk, raises financing costs, and materially reduces strategic and operational flexibility over the medium term.

ORGC FAQ

What was OrganoClick AB’s price range in the past 12 months?
OrganoClick AB lowest stock price was kr1.30 and its highest was kr2.98 in the past 12 months.
    What is OrganoClick AB’s market cap?
    OrganoClick AB’s market cap is kr184.26M.
      When is OrganoClick AB’s upcoming earnings report date?
      OrganoClick AB’s upcoming earnings report date is May 06, 2026 which is in 64 days.
        How were OrganoClick AB’s earnings last quarter?
        OrganoClick AB released its earnings results on Feb 12, 2026. The company reported -kr0.1 earnings per share for the quarter, missing the consensus estimate of -kr0.07 by -kr0.03.
          Is OrganoClick AB overvalued?
          According to Wall Street analysts OrganoClick AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does OrganoClick AB pay dividends?
            OrganoClick AB does not currently pay dividends.
            What is OrganoClick AB’s EPS estimate?
            OrganoClick AB’s EPS estimate is -0.02.
              How many shares outstanding does OrganoClick AB have?
              OrganoClick AB has 110,003,010 shares outstanding.
                What happened to OrganoClick AB’s price movement after its last earnings report?
                OrganoClick AB reported an EPS of -kr0.1 in its last earnings report, missing expectations of -kr0.07. Following the earnings report the stock price went down -9.639%.
                  Which hedge fund is a major shareholder of OrganoClick AB?
                  Currently, no hedge funds are holding shares in SE:ORGC
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    OrganoClick AB

                    OrganoClick AB (publ), a material and chemical technology company, develops, produces, and markets fiber-based materials and chemicals for treatment of wood, technical textile and nonwoven, and bio composites in Sweden. It offers OrganoWood, a wood preservative technology and wood preservative that gives wood enhanced durability against rot and fire primarily for construction companies and consumers; OrganoTex, a biodegradable durable water repellent technology and textile treatment that makes textile products water repellent, as well as offers shoe and clothes care products; and OrganoComp, a biobased plastic-free and degradable bio-composite used for making 3D-shaped objects that replaces hard plastic materials. The company also provides consumer products, including a range of maintenance and cleaning products for wood, facades, roofs, and terraces, as well as for car care under the BIOkleen name; OC-BioBinder, a biobased, plastic-free, and degradable binder used by industrial customers as a replacement for plastic binders in nonwoven and technical textiles; and OC-AquaSil Tex, a biodegradable hydrophobing product used to replace PFAS in nonwovens, specialty papers, and technical textiles. The company was founded in 2006 and is headquartered in Täby, Sweden.

                    OrganoClick AB (ORGC) Earnings & Revenues

                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Nexam Chemical Holding AB
                    Svenska Aerogel Holding AB
                    Polygiene AB
                    Impact Coatings AB
                    XP Chemistries AB
                    Popular Stocks